Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 16/20 | 0.72 |
| ▸ | CPT2 | P23786 | 2/20 | 0.52 |
| ▸ | CPT1A | P50416 | 2/20 | 0.52 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.52 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1654830 | 0.99 | FAAH (0.71) | FAAHCPT2CPT1ACPT1BHSD11B1 | |
| SCHEMBL10040539 | 0.91 | FAAH (0.64) | FAAHCPT2CPT1ACPT1BHSD11B1 | |
| SCHEMBL10040540 | 0.89 | FAAH (0.61) | FAAHCPT2CPT1ACPT1B | |
| SCHEMBL10040541 | 0.87 | FAAH (0.65) | FAAHCPT2CPT1ACPT1B | |
| SCHEMBL10070073 | 0.80 | FAAH (0.53) | FAAHHSD11B1 | |
| SCHEMBL3766417 | 0.80 | FAAH (0.61) | FAAHCPT2CPT1ACPT1B | |
| SCHEMBL18711437 | 0.80 | SPR (0.53) | FAAHCPT2CPT1ACPT1BHSD11B1 | |
| SCHEMBL3763231 | 0.79 | FAAH (0.61) | FAAHCPT1AHSD11B1 | |
| SCHEMBL1653297 | 0.78 | USP30 (0.59) | FAAH | |
| SCHEMBL1652509 | 0.78 | FAAH (0.49) | FAAHCPT2CPT1AHSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8207199-B2 | Azole compound | ASTELLAS PHARMA INC. (JP) | 2012-06-26 | — | — | US | disclosed |
| US-8207199-B2 | Azole compound | ASTELLAS PHARMA INC. (JP) | 2012-06-26 | — | — | US | disclosed |
| US-20110118311-A1 | AZOLE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2011-05-19 | — | — | US | disclosed |
| US-20110118311-A1 | AZOLE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2011-05-19 | — | — | US | disclosed |
| WO-2010007966-A1 | AZOLE COMPOUND | アステラス製薬株式会社 (JP) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118311-A1 | AZOLE COMPOUND | FAAH, FAAH2, TRPV1 | FAAH 1/4885CPT2 2583/4885CPT1A 1233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.